Reliance Global Announces Enquantum Completes 5G Deployment With Israeli Construction Firm
Reliance Global Announces 1-For-40 Reverse Stock Split
Reliance Global Group, Inc. (EZRA) Q1 2026 Earnings Call Transcript
Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments
Reliance Global Group Q1 EPS $(0.09) Up From $(0.66) YoY, Sales $3.827M Down From $4.236M YoY
Reliance Global Group Schedules First Quarter 2026 Financial Results and Business Update Conference Call
Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment
Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA’s Biotech Division
Reliance Global Group Increases Ownership in Enquantum to 29% Following Achievement of Defined Technical and Commercial Milestones
Reliance Global Group Increases Its Equity Position In Enquantum To ~29%
Reliance Global Group to Participate in Centri Capital Conference at Nasdaq MarketSite in New York City on April 14, 2026
Reliance Global Group Launches RELI Exchange 2.0 to Drive Faster, More Efficient Growth
Reliance Global Group Funds Next Enquantum Milestone, Increasing Ownership and Securing Additional Board Seat
Reliance Global Finances Its Next Completed Milestone In Its Strategic Investment In Enquantum
Reliance Global Group shares are trading lower after the company reported a year-over-year decrease in its Q4 financial results.
Reliance Global Group Inc (EZRA) Q4 2025 Earnings Call Highlights: Strategic Growth and ...
Reliance Global Group Reports 2025 Results and Provides Strategic Update on Scale51 Initiative and Launch of EZRA International Group
Reliance Global Group, Inc. (EZRA) Q4 2025 Earnings Call Transcript
Reliance Global Group Q4 EPS $0.43 Down From $1.55 YoY, Sales $2.613M Down From $3.297M YoY
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.